Prognostic value of metabolic tumor volume and total lesion glycolysis from 18F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage i non-small-cell lung cancer

Nuclear Medicine Communications

Volumn 34, Issue 10, 2013, Pages 959-963

  Vu, Charles C ^a   Matthews, Robert ^a   Kim, Bong ^a   Franceschi, Dinko ^a   Bilfinger, Thomas V ^a   Moore, William H ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

lung cancer; metabolic tumor volume; PET; stereotactic ablative radiotherapy; stereotactic body radiation therapy; total lesion glycolysis

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; FOLLOW UP; GLYCOLYSIS; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; LUNG NON SMALL CELL CANCER; MALE; METABOLIC TUMOR VOLUME; OVERALL SURVIVAL; PREDICTION; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TOTAL LESION GLYCOLYSIS; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; HUMANS; LUNG NEOPLASMS; MALE; MULTIMODAL IMAGING; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOSURGERY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84883655009     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32836491a9     Document Type: Article

References (20)

1. Timmerman R, Paulus R, Galvin J., Michalski J, Straube W, Bradley J., et al Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070-1076.
2. Takeda A, Yokosuka N, Ohashi T., Kunieda E, Fujii H, Aoki Y., et al The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT). Radiother Oncol 2011; 101:291-297.
3. Clarke K, Taremi M, Dahele M., Freeman M, Fung S, Franks K., et al Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome? Radiother Oncol 2012; 104:62-66.
4. 18F-FDG-PET uptake 12 weeks after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer predicts local control. Int J Radiat Oncol Biol Phys 2012; 83:e551-e555.
5. Hoopes DJ, Tann M, Fletcher J.W., Forquer JA, Lin PF, Lo SS, et al FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer. Lung Cancer 2007; 56:229-234. (Pubitemid 46590486)
6. Burdick MJ, Stephans KL, Reddy C.A., Djemil T., Srinivas SM, Videtic GM Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78:1033-1039.
7. Zhang X, Liu H, Balter P., Allen PK, Komaki R, Pan T, et al Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2012; 83: 1558-1565.
8. Zhang H, Wroblewski K, Liao S., Kampalath R, Penney BC, Zhang Y, et al Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Acad Radiol 2013; 20:32-40.
9. Zaizen Y, Azuma K, Kurata S., Sadashima E, Hattori S, Sasada T., et al Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy. Eur J Radiol 2012; 81:4179-4184.
10. Abelson JA, Murphy JD, Trakul N, Bazan J.G., Maxim PG, Graves EE, et al Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy. Lung Cancer 2012; 78:219-224.
11. Werner-Wasik M., Nelson AD, Choi W, Arai Y., Faulhaber PF, Kang P, et al What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom. Int J Radiat Oncol Biol Phys 2012; 82:1164-1171.
12. Larson SM, Erdi Y, Akhurst T., Mazumdar M, Macapinlac HA, Finn R.D., et al Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging 1999; 2:159-171.
13. Bishawi M, Kim B, Moore W.H., Bilfinger TV Pulmonary function testing after stereotactic body radiotherapy to the lung. Int J Radiat Oncol Biol Phys 2012; 82:e107-e110.
14. Paesmans M, Berghmans T, Dusart M., Garcia C, Hossein-Foucher C Lafitte JJ, et al. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol 2010; 5:612-619.
15. Coon D, Gokhale AS, Burton S.A., Heron DE, Ozhasoglu C, Christie N. Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning. Clin Lung Cancer 2008; 9:217-221.
16. Gill BS, Rivandi AH, Sandhu S.P., Jensen LG, Nobiensky PD, Hoh CK, et al The role of positron emission tomography following radiosurgical treatment of malignant lung lesions. Nucl Med Commun 2012; 33:607-612.
17. Satoh Y, Nambu A, Onishi H., Sawada E, Tominaga L, Kuriyama K., et al Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy. Eur J Radiol 2012; 81:3530-3534.
18. Chang JY, Liu H, Balter P., Komaki R, Liao Z, Welsh J.W., et al Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 2012; 7:152.
19. Hyun SH, Choi JY, Kim K, Kim J., Shim YM, Um SW, et al Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection. Ann Surg 2013; 257:364-370.
20. Kim K, Kim SJ, Kim I.J., Kim YS, Pak K, Kim H. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer. Nucl Med Commun 2012; 33:613-620.